Patent Assignment
Reel/Frame 016793/0407
Merger
Recorded: 2005-11-18
Pages: 8
Assignor
PANACOS PHARMACEUTICALS, INC.
Executed: 2005-03-11
Assignee
V.I. TECHNOLOGIES, INC.
134 COOLIDGE AVENUE, WATERTOWN, MASSACHUSETTS, 02472
Covered Properties
(33)
Suksdorfin Analogs, Compositions Thereof and Methods for Making and Using Thereof Including Treatment of Retroviral Related Pathologies
Application:
08/142,992 →
Suksdorfin Analogs, Compositions Thereof and Methods for Making and Using Thereof Including Treatment of Retroviral Related Pathologies
Application:
08/235,852 →
Suksdorfin, Analogs, Compositions Thereof, and Methods for Making and Using Thereof
Patent:
5,637,589 →
Application:
08/392,558 →
Suksdorfin Analogs, Compositions Thereof, and Methods for Making and Using Thereof
Patent:
5,726,204 →
Application:
08/462,280 →
Betulinic Acid and Dihydrobetulinic Acid Derivatives and Uses Thereof
Patent:
5,679,828 →
Application:
08/463,071 →
Brominated Hexahydroxybiphenyl Derivatives
Patent:
5,612,341 →
Application:
08/477,939 →
Suksdorfin Analogs, Compositions Thereof, and Methods for Making and Using Thereof
Patent:
5,847,165 →
Application:
08/604,305 →
Suksdorfin Analogs, Compositions Thereof, and Methods for Making and Using Thereof
Patent:
6,319,929 →
Application:
09/207,500 →
Acylated Betulin and Dihydrobetulin Derivatives, Preparation Thereof and Use Thereof
Patent:
6,172,110 →
Application:
09/260,078 →
Methods of Eliciting Broadly Neutralizing Antibodies Targeting Hiv-1 GP41
Application:
09/480,336 →
Assay for Detection of Viral Fusion Inhibitors
Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins
Application:
09/809,060 →
Publication:
US 2002/0010317
Substituted 3',4' -Di-O-Camphanoyl-(+)-Cis-Khellactone Analogs, Compositions Thereof, and Methods for Using Thereof
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
Application:
10/670,797 →
Publication:
US 2004/0131629
Method for detecting viral inactivating agents
Application:
10/685,801 →
Publication:
US 2004/0132011
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
Application:
10/766,528 →
Publication:
US 2004/0265320
Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
Monoacylated Betulin and Dihydrobetulin Derivatives, Preparation Thereof and Use Thereof
Triterpene derivatives, preparation thereof and use thereof
Application:
10/949,875 →
Publication:
US 2005/0148561
Acylated Betulin and Dihydrobetulin Derivatives, Preparation Thereof and Use Thereof
Application:
60/076,449 →
Methods of Eliciting Broadlv Netralizing Antibodies Targeting Hiv-1GP41
Application:
60/115,404 →
Assay for detection of viral fusion inhibitors
Application:
60/181,543 →
Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins
Application:
60/189,981 →
Assay for detection of viral fusion inhibitors
Application:
60/235,901 →
Substituted 3' , 4' -di-O-camphanoyl- (+) -cis-khellactone analogs, compositions thereof, and methods for using thereof
Application:
60/275,043 →
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
Application:
60/413,451 →
Inhibition of HIV-1 replication by disruption of the processing of the viral gag capsid (CA) protein from the Ca-spacer peptide 1 protein precursor
Application:
60/443,180 →
Molecular target for compounds that inhibit HIV-1 replication by disrupting the processing of the HIV-1 Gag capsid (CA) protein from the CA-spacer peptide 1 protein precursor
Application:
60/496,660 →
Novel triterpene derivatives, preparation thereof and use thereof
Application:
60/505,899 →
Pharmaceutical salts of 3-O-(3'3'-dimethylsuccinyl) betulinic acid
Application:
60/553,554 →
Novel triterpene derivatives, preparation thereof and use thereof
Application:
60/559,358 →
Pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
Application:
60/584,674 →
Polymorphs of 3-O-(3',3'-dimethylsuccinyl)betulinic acid di-N-methyl -D-glucamine
Application:
60/670,227 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2004
From: WILD, CARL T.; ROBINSON, GARY N.
To: PANACOS PHARMACEUTICALS INC.
Reel/Frame 014281/0716 →
Assignment of Assignor's Interest
Feb 2, 2004
From: LI, FENG; WILD, CARL T.; ALLAWAY, GRAHAM P.
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 014298/0262 →
Assignment of Assignor's Interest
Feb 2, 2004
From: SALZWEDEL, KARL; LI, FENG; WILD, CARL T.; ALLAWAY, GRAHAM P.
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 014298/0202 →
Assignment of Assignor's Interest
Feb 2, 2004
From: ALLAWAY, GRAHAM P.; WILD, CARL T.; SALZWEDEL, KARL
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 014298/0178 →
Assignment of Assignor's Interest
Jun 14, 2005
From: FREED, ERIC O.
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 016137/0832 →
Assignment of Assignor's Interest
Jun 14, 2005
From: FREED, ERIC O.
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 016137/0774 →
Technology Transfer Agreement
Aug 12, 2005
From: BBI BIOTECH RESEARCH LABORATORIES, INC.
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 016392/0827 →
Change of Name
Nov 18, 2005
From: V.I. TECHNOLOGIES, INC.
To: PANACOS PHARMACEUTICALS, INC.
Reel/Frame 016793/0400 →
Executive Order 9424, Confirmatory License
Jun 6, 2008
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021081/0505 →
Assignment of Assignor's Interest
Feb 12, 2009
From: PANACOS PHARMACEUTICALS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 022250/0741 →
Confirmatory License
Feb 26, 2010
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023998/0539 →
Confirmatory License
Mar 1, 2010
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024006/0055 →
Confirmatory License
Mar 1, 2010
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024006/0062 →
Confirmatory License
Mar 1, 2010
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024006/0057 →
Assignment of Assignor's Interest
May 12, 2010
From: PANACOS PHARMACEUTICALS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 024369/0690 →
Change of Name
Aug 17, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024849/0115 →
Change of Name
Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024856/0683 →
Change of Name
Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0944 →